152 participants
Tesetaxel Plus Reduced Dose of Capecitabine in Patients With HER2 Negative, HR Positive, LA/MBC
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-07-30
- Start Date:
- 2019-02-05
- Completion:
- 2021-06-11
Conditions
- Breast Cancer
Interventions
- DRUG
No Results Yet